Mucoadhesive Electrospun Patch Delivery of Lidocaine to the Oral Mucosa and Investigation of Spatial Distribution in a Tissue Using MALDI-Mass Spectrometry Imaging.
Administration, Buccal
Anesthetics
/ administration & dosage
Animals
Cell Line, Tumor
Drug Delivery Systems
/ methods
Drug Liberation
Facial Pain
/ drug therapy
Humans
Lidocaine
/ administration & dosage
Mouth Mucosa
/ drug effects
Neuroblastoma
/ metabolism
Oral Mucosal Absorption
/ physiology
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
/ methods
Swine
Tissue Distribution
Veratridine
/ pharmacology
Voltage-Gated Sodium Channel Agonists
/ pharmacology
Voltage-Gated Sodium Channel Blockers
/ administration & dosage
MALDI-mass spectrometry imaging
drug distribution in tissue
electrospinning
ex vivo tissue permeation
lidocaine
oral mucosa
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
03 09 2019
03 09 2019
Historique:
pubmed:
31
7
2019
medline:
9
6
2020
entrez:
31
7
2019
Statut:
ppublish
Résumé
Many oral mucosal conditions cause considerable and prolonged pain that to date has been difficult to alleviate via topical delivery, and the use of injection causes many patients dental anxiety and needle-prick pain. Therefore, developing a noninjectable drug delivery system as an alternative administration procedure may vastly improve the health and wellbeing of these patients. Recent advances in the development of mucoadhesive electrospun patches for the direct delivery of therapeutics to the oral mucosa offer a potential solution, but as yet, the release of local anesthetics from this system and their uptake by oral tissue have not been demonstrated. Here, we demonstrate the fabrication of lidocaine-loaded electrospun fiber patches, drug release, and subsequent uptake and permeation through the porcine buccal mucosa. Lidocaine HCl and lidocaine base were incorporated into the electrospun patches to evaluate the difference in drug permeation for the two drug compositions. Lidocaine released from the lidocaine HCl-containing electrospun patches was significantly quicker than from the lidocaine base patches, with double the amount of drug released from the lidocaine HCl patches in the first 15 min (0.16 ± 0.04 mg) compared to that from the lidocaine base patches (0.07 ± 0.01 mg). The permeation of lidocaine from the lidocaine HCl electrospun patches through ex vivo porcine buccal mucosa was also detected in 15 min, whereas permeation of lidocaine from the lidocaine base patch was not detected. Matrix-assisted laser desorption ionization-mass spectrometry imaging was used to investigate localization of lidocaine within the oral tissue. Lidocaine in the solution as well as from the mucoadhesive patch penetrated into the buccal mucosal tissue in a time-dependent manner and was detectable in the lamina propria after only 15 min. Moreover, the lidocaine released from lidocaine HCl electrospun patches retained biological activity, inhibiting veratridine-mediated opening of voltage-gated sodium channels in SH-SY5Y neuroblastoma cells. These data suggest that a mucoadhesive electrospun patch may be used as a vehicle for rapid uptake and sustained anesthetic drug delivery to treat or prevent oral pain.
Identifiants
pubmed: 31361498
doi: 10.1021/acs.molpharmaceut.9b00535
pmc: PMC7007276
doi:
Substances chimiques
Anesthetics
0
Voltage-Gated Sodium Channel Agonists
0
Voltage-Gated Sodium Channel Blockers
0
Veratridine
71-62-5
Lidocaine
98PI200987
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3948-3956Références
Carbohydr Polym. 2015 Nov 5;132:173-9
pubmed: 26256338
J Control Release. 2003 Mar 7;88(2):277-85
pubmed: 12628334
Pharm Res. 2018 Feb 21;35(3):70
pubmed: 29468320
Pharmaceutics. 2011 Sep 27;3(4):665-79
pubmed: 24309302
Int J Paediatr Dent. 2008 Nov;18(6):452-60
pubmed: 18341564
Anal Chem. 2015 Jan 6;87(1):64-82
pubmed: 25490190
ACS Appl Mater Interfaces. 2017 Apr 5;9(13):11557-11567
pubmed: 28299922
Eur J Pharm Biopharm. 2007 Jun;66(3):422-8
pubmed: 17196804
J Dent Anesth Pain Med. 2016 Dec;16(4):237-244
pubmed: 28879311
Anal Bioanal Chem. 2014 Jun;406(15):3735-42
pubmed: 24722877
Rev Physiol Biochem Pharmacol. 1998;133:1-54
pubmed: 9600010
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Mol Pharm. 2018 Feb 5;15(2):519-526
pubmed: 29226683
Biotechnol Bioeng. 2010 Feb 1;105(2):396-408
pubmed: 19731254
Eur J Pharm Biopharm. 2013 Apr;83(3):405-14
pubmed: 23159712
Int J Pharm. 2016 Sep 10;511(1):599-605
pubmed: 27426107
Biomaterials. 2008 May;29(13):1989-2006
pubmed: 18281090
J Am Chem Soc. 2014 Apr 30;136(17):6401-5
pubmed: 24708172
FASEB J. 2012 Jun;26(6):2667-73
pubmed: 22389441
Int J Pharm. 2013 Nov 30;457(1):168-76
pubmed: 24050988
Carbohydr Polym. 2015 Mar 6;117:933-40
pubmed: 25498719
Mol Pharm. 2017 Mar 6;14(3):808-820
pubmed: 28195483
Int J Pharm. 2008 Nov 19;364(1):87-93
pubmed: 18771719
Int J Pharm. 2011 Dec 12;421(1):53-62
pubmed: 21963468
J Proteomics. 2012 Aug 30;75(16):5106-5110
pubmed: 22842151
Nanotechnology. 2009 Feb 4;20(5):055104
pubmed: 19417335
J Control Release. 2018 Dec 28;292:91-110
pubmed: 30118788
J Clin Pharmacol. 2003 Feb;43(2):111-7
pubmed: 12616661
Biochem Pharmacol. 2012 Jun 1;83(11):1562-71
pubmed: 22410003
Drug Dev Ind Pharm. 2004;30(9):985-93
pubmed: 15554223
Cancer Nurs. 2002 Dec;25(6):461-7; quiz 468-9
pubmed: 12464838
Eur J Pharm Biopharm. 2011 Feb;77(2):187-99
pubmed: 21130875
AAPS PharmSciTech. 2013 Dec;14(4):1341-8
pubmed: 23990076
AAPS PharmSciTech. 2008;9(2):501-4
pubmed: 18431653
J Dent. 2009 Sep;37(9):700-4
pubmed: 19556053
J Control Release. 2003 Oct 30;92(3):349-60
pubmed: 14568415
Biomaterials. 2018 Sep;178:134-146
pubmed: 29929183
Eur J Pharm Biopharm. 2010 Jun;75(2):179-85
pubmed: 20144711
Adv Drug Deliv Rev. 2007 Jul 30;59(7):617-30
pubmed: 17597252
AAPS PharmSciTech. 2013 Dec;14(4):1279-83
pubmed: 23959703
J Am Soc Mass Spectrom. 2013 May;24(5):718-21
pubmed: 23536269